Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)
Overview
Authors
Affiliations
Purpose: GOG-259 was a 3-arm randomized controlled trial of two web-based symptom management interventions for patients with recurrent ovarian cancer. Primary aims were to compare the efficacy of the nurse-guided (Nurse-WRITE) and self-directed (SD-WRITE) interventions to Enhanced Usual Care (EUC) in improving symptoms (burden and controllability) and quality of life (QOL).
Methods: Patients with recurrent or persistent ovarian, fallopian, or primary peritoneal cancer with 3+ symptoms were eligible for the study. Participants completed baseline (BL) surveys (symptom burden and controllability and QOL) before random assignment. WRITE interventions lasted 8 weeks to develop symptom management plans for three target symptoms. All women received EUC: monthly online symptom assessment with provider reports; online resources; and every 2-week e-mails. Outcomes were evaluated at 8 and 12 weeks after BL. Repeated-measures modeling with linear contrasts evaluated group by time effects on symptom burden, controllability, and QOL, controlling for key covariates.
Results: Participants (N = 497) reported mean age of 59.3 ± 9.2 years. At BL, 84% were receiving chemotherapy and reported a mean of 14.2 ± 4.9 concurrent symptoms, most commonly fatigue, constipation, and peripheral neuropathy. Symptom burden and QOL improved significantly over time ( < .001) for all three groups. A group by time interaction ( < .001) for symptom controllability was noted whereby both WRITE intervention groups had similar improvements from BL to 8 and 12 weeks, whereas EUC did not improve over time.
Conclusion: Both WRITE Intervention groups showed significantly greater improvements in symptom controllability from BL to 8 and BL to 12 weeks compared with EUC. There were no significant differences between Nurse-WRITE and SD-WRITE. SD-WRITE has potential as a scalable intervention for a future implementation study.
Bartel C, Chen L, Huang W, Li Q, Li Q, Fedor J JMIR Cancer. 2025; 11():e62711.
PMID: 39801398 PMC: 11741193. DOI: 10.2196/62711.
Campbell G, Kim H, Klinedinst T, Klinger J, Lee Y, Donovan H JMIR Cancer. 2024; 10:e48465.
PMID: 39361371 PMC: 11487211. DOI: 10.2196/48465.
Thomas T, Campbell G, Tan K, Murray P, Loughlin K, Roberge M JCO Oncol Pract. 2024; :OP2400383.
PMID: 39167743 PMC: 11842612. DOI: 10.1200/OP.24.00383.
Wang Y, DeVito Dabbs A, Thomas T, Campbell G, Donovan H JMIR Form Res. 2024; 8:e57529.
PMID: 39037757 PMC: 11301115. DOI: 10.2196/57529.
Women with ovarian cancer's information seeking and avoidance behaviors: an interview study.
Chi Y, Hui V, Kunsak H, Brusilovsky P, Donovan H, He D JAMIA Open. 2024; 7(1):ooae011.
PMID: 38384330 PMC: 10881099. DOI: 10.1093/jamiaopen/ooae011.